bpc 157 not working BPC-157 vs. TB-500: What Patients Should Know BPC-157: Experimental Peptide Creates Risk

Only one Phase I clinical trial has been registered, and no Phase 2 or 3 trials have been completed

WHITE PLAINS, NEW YORK JANUARY 13, 2009 A report by ConsumerLab.com on supplements containing the anti-oxidant CoQ10 shows the difficulty for consumers in determining an appropriate dosage

whereas cyanocobalamin does not have this effect (7)

Always follow the dosage and frequency recommended by your healthcare provider

Patients with diabetes or those on insulin or other glucose-lowering medications should have glucose levels monitored closely when starting or adjusting sermorelin therapy, as dosage adjustments to their diabetes medications may be needed